The number of people with susceptibility test result for rifampicin in Luxembourg
Luxembourg: The number of people with susceptibility test result for rifampicin was 21 in 2021. ◆ Volatile
Latest (2021)
21
Change on year
up 16.7%
World rank
132nd
of 155 countries
All-time high
21
in 2021
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Luxembourg, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Luxembourg is 21, measured in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 16.7% on the previous year.
Luxembourg ranks 132nd of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Luxembourg, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 16 | — |
| 2020 | 18 | +12.5% |
| 2021 | 21 | +16.7% |
Luxembourg compared with similar countries
- Luxembourg's 21 is below the median for high income countries, which is 142, 15% of the median. (61 countries reporting)
- Luxembourg's 21 is below the median for Europe & Central Asia, which is 229.5, 9% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5.33 | 0 | 16 | 3 |
| 2020s | 19.5 | 18 | 21 | 2 |
Countries ranked near Luxembourg
- 129 Micronesia, Federated States of 27 compare
- 129 Malta 27 compare
- 131 United Arab Emirates 23 compare
- 133 Tuvalu 19 compare
- 134 France 17 compare
- 135 New Caledonia 15 compare
More health data for Luxembourg
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,220 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.63 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0253 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.27 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Luxembourg?
- The number of people with susceptibility test result for rifampicin in Luxembourg was 21 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Luxembourg?
- The highest recorded value was 21 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Luxembourg?
- The lowest recorded value was 0 in 2017.
- How does Luxembourg rank for the number of people with susceptibility test result for rifampicin?
- Luxembourg ranks 132nd out of 155 countries with data for 2021.
- Where does this Luxembourg data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).